Merck ($MRK) filed an 8‑K on Feb 3, 2026 furnishing a press release (Exh.99.1) with Q4 & FY2025 earnings.
Filed with the SEC on · Summarized by InvestorsBot
Merck ($MRK) filed an 8‑K on Feb 3, 2026 furnishing a press release (Exh.99.1) with Q4 & FY2025 earnings. Earnings release now furnished to the SEC — review the release for results and any guidance. 📣 #Earnings #Pharma
The 8‑K also furnishes Exhibit 99.2 (supplemental info not in the press release) and Exhibit 104 (Inline XBRL cover page). Investors should review the supplements for additional financial detail and reconciliations. 📊 $MRK #SECfiling #Investing
Form 8‑K signed Feb 3, 2026 by Kelly E. W. Grez, Corporate Secretary. Note Item 9.01 indicates exhibits were furnished (not filed); consult the Feb 3 press release and supplemental exhibits for the full Q4 & FY2025 figures and context. 📝 $MRK #Earnings #SECfiling